Ladenburg Thalmann Financial Services’s SELLAS Life Sciences SLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Hold
0
5481
2019
Q3
Hold
0
5425
2019
Q2
Hold
0
5385
2019
Q1
Sell
-3
Closed -$209 5314
2018
Q4
$0 Hold
3
﹤0.01% 5316
2018
Q3
$0 Hold
3
﹤0.01% 5291
2018
Q2
$0 Hold
3
﹤0.01% 5140
2018
Q1
$0 Buy
3
+2
+200% +$571 ﹤0.01% 5186
2017
Q4
$0 Hold
1
﹤0.01% 5103
2017
Q3
$0 Hold
1
﹤0.01% 5008
2017
Q2
$0 Hold
1
﹤0.01% 4951
2017
Q1
$0 Buy
+1
New +$1.66K ﹤0.01% 4952
2016
Q4
Hold
0
4701

Other funds holding SLS

Ladenburg Thalmann Financial Services's SLS Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its SELLAS Life Sciences (SLS) position steady in Q4 2019 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5481.

Ladenburg Thalmann Financial Services first reported a position in SLS in Q1 2017 and has held it in 8 quarters since. The position peaked at $0 in Q4 2018. 11 funds tracked by Wall St. Rank hold SLS as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 0 shares of SELLAS Life Sciences worth $0 as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its SELLAS Life Sciences share count unchanged in Q4 2019.
  • SELLAS Life Sciences made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5481 holding.
  • Ladenburg Thalmann Financial Services first reported a position in SELLAS Life Sciences in Q1 2017 and has held it in 8 quarters since.
  • Ladenburg Thalmann Financial Services's SELLAS Life Sciences position peaked at $0 in Q4 2018.
  • 11 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.